
Rx/Reimbursement Adult Incontinence in the US
Description
Rx/Reimbursement Adult Incontinence in the US
Rising consumer awareness around incontinence and proper condition management, partnerships with direct-to-consumer platforms and the expanding 65+ year-old population in the US all contributed to healthy value and volume growth in the Rx/reimbursement adult incontinence market in 2023.
Euromonitor International's Rx/Reimbursement adult incontinence in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2028 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
21 Pages
- Rx/Reimbursement Adult Incontinence in the US
- Euromonitor International
- February 2024
- List Of Contents And Tables
- RX/REIMBURSEMENT ADULT INCONTINENCE IN THE US
- KEY DATA FINDINGS
- 2023 DEVELOPMENTS
- Rx/reimbursement continues to see steady growth, even amid the cessation of COVID-19 emergency relief funding
- Funding constraints limit product options
- Florida lawsuit settlements prompt expanded coverage of incontinence products
- PROSPECTS AND OPPORTUNITIES
- Future policy will be a key driver of the category’s long-term performance
- Brands and direct-to-consumer retailers’ education and alliances are essential for the reimbursement consumer
- CATEGORY DATA
- Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2018-2023
- Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2018-2023
- Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2023-2028
- Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2023-2028
- TISSUE AND HYGIENE IN THE US
- EXECUTIVE SUMMARY
- Tissue and hygiene in 2023: The big picture
- 2023 key trends
- Competitive landscape
- Retailing developments
- What next for tissue and hygiene?
- MARKET INDICATORS
- Table 5 Birth Rates 2018-2023
- Table 6 Infant Population 2018-2023
- Table 7 Female Population by Age 2018-2023
- Table 8 Total Population by Age 2018-2023
- Table 9 Households 2018-2023
- Table 10 Forecast Infant Population 2023-2028
- Table 11 Forecast Female Population by Age 2023-2028
- Table 12 Forecast Total Population by Age 2023-2028
- Table 13 Forecast Households 2023-2028
- MARKET DATA
- Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2018-2023
- Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2018-2023
- Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2019-2023
- Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2020-2023
- Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2018-2023
- Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2018-2023
- Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2023
- Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2023-2028
- Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2023-2028
- DISCLAIMER
- SOURCES
- Summary 1 Research Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.